Title:
脳腫瘍の処置のための治療剤としての２−アミノピリミジン誘導体
Document Type and Number:
Japanese Patent JP6908287
Kind Code:
B2
Abstract:
Methods of using substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, or compositions, for the treatment of brain cancers, in particular EGFR-mediated metastatic brain cancer, are disclosed.
Inventors:
Greco, Michael, Nicholas
Costanzo, Michael, John
Green, michael, alan
Pen, giron
Wild, victorian, lynn
Chan, Don
Costanzo, Michael, John
Green, michael, alan
Pen, giron
Wild, victorian, lynn
Chan, Don
Application Number:
JP2018559217A
Publication Date:
July 21, 2021
Filing Date:
May 11, 2017
Export Citation:
Assignee:
Beta Pharma, Inc.
International Classes:
A61K31/506; A61P25/00; A61P35/00; A61P35/04; A61P43/00
Foreign References:
| CN105085489A | ||||
| WO2016029839A1 |
Other References:
Eur. Respir.J.,2011年,Vol.37,P.624-631,Abstract、Table2
Expert Opin. Investig. Drugs,2014年,Vol.23/No.7,P.1-11,Abstract
Expert Opin. Investig. Drugs,2014年,Vol.23/No.7,P.1-11,Abstract
Attorney, Agent or Firm:
Hatta International Patent Corporation